David Melnick

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety

Urania Rappo, Sailaja Puttagunta, V. G. Shevchenko et al. · Open Forum Infectious Diseases · 2018 · 207 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of <i>Pseudomonas aeruginosa</i>

Vincent H. Tam, Amy N. Schilling, Shádi Neshat et al. · Antimicrobial Agents and Chemotherapy · 2005 · 196 citations · Full text

Life Sciences, Microbiology, Pharmacology +16

Identification of broadly protective human antibodies to<i>Pseudomonas aeruginosa</i>exopolysaccharide Psl by phenotypic screening

Antonio DiGiandomenico, Paul Warrener, Melissa Hamilton et al. · The Journal of Experimental Medicine · 2012 · 177 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes.

R Sullivan, J D Griffin, E R Simons et al. · The Journal of Immunology · 1987 · 156 citations

Life Sciences, Cell Biology, Immunology +15

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

Thomas P. Lodise, F. Sörgel, David Melnick et al. · Antimicrobial Agents and Chemotherapy · 2011 · 122 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17